194 related articles for article (PubMed ID: 11293903)
41. Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.
Schoch C; Schnittger S; Kern W; Dugas M; Hiddemann W; Haferlach T
Haematologica; 2003 Mar; 88(3):351-2. PubMed ID: 12651278
[No Abstract] [Full Text] [Related]
42. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
43. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
Blum W; Mrózek K; Ruppert AS; Carroll AJ; Rao KW; Pettenati MJ; Anastasi J; Larson RA; Bloomfield CD
Cancer; 2004 Sep; 101(6):1420-7. PubMed ID: 15368330
[TBL] [Abstract][Full Text] [Related]
44. [Clinical study of 572 adult acute leukemia patients in Shanghai according to WHO classification].
Sino US Leukemia Cooperative Group of Shanghai
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):444-8. PubMed ID: 18072625
[TBL] [Abstract][Full Text] [Related]
45. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.
Morerio C; Rapella A; Tassano E; Rosanda C; Panarello C
Leuk Res; 2005 Oct; 29(10):1223-6. PubMed ID: 16111539
[TBL] [Abstract][Full Text] [Related]
46. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
47. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
48. New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues.
Falini B; Tiacci E; Martelli MP; Ascani S; Pileri SA
Discov Med; 2010 Oct; 10(53):281-92. PubMed ID: 21034669
[TBL] [Abstract][Full Text] [Related]
49. Clinical importance of cytogenetics in acute myeloid leukaemia.
Mrózek K; Heinonen K; Bloomfield CD
Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
[TBL] [Abstract][Full Text] [Related]
50. Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.
Lu G; Yin CC; Medeiros LJ; Abruzzo LV
Cancer Genet Cytogenet; 2009 Jan; 188(2):118-23. PubMed ID: 19100517
[TBL] [Abstract][Full Text] [Related]
51. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
52. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
[TBL] [Abstract][Full Text] [Related]
53. [Significance of WHO classification for acute leukemia and myelodysplastic syndrome].
Sugiura A; Takeshita A
Rinsho Byori; 2006 Nov; 54(11):1178-86. PubMed ID: 17240841
[TBL] [Abstract][Full Text] [Related]
54. Laboratory diagnosis of acute myeloid leukaemia.
Swirsky DM; Richards SJ
Best Pract Res Clin Haematol; 2001 Mar; 14(1):1-17. PubMed ID: 11355921
[TBL] [Abstract][Full Text] [Related]
55. Morphology and classification of acute myeloid leukemias.
Krause JR
Clin Lab Med; 2000 Mar; 20(1):1-16. PubMed ID: 10702892
[TBL] [Abstract][Full Text] [Related]
56. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
57. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
58. Cytochemical and immunological aspects of the acute lymphocytic leukemias (as related to FAB classification).
Palutke M; Tabaczka P
Ann Clin Lab Sci; 1980; 10(4):269-75. PubMed ID: 6969569
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
[TBL] [Abstract][Full Text] [Related]
60. Unique molecular and cellular features of acute myelogenous leukemia stem cells.
Jordan CT
Leukemia; 2002 Apr; 16(4):559-62. PubMed ID: 11960332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
